clofibric acid has been researched along with Dementia in 1 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Overall 32." | 1.33 | APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. ( Alpérovitch, A; Amouyel, P; Dartigues, JF; Dufouil, C; Fiévet, N; Richard, F; Ritchie, K; Tzourio, C, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dufouil, C | 1 |
| Richard, F | 1 |
| Fiévet, N | 1 |
| Dartigues, JF | 1 |
| Ritchie, K | 1 |
| Tzourio, C | 1 |
| Amouyel, P | 1 |
| Alpérovitch, A | 1 |
1 other study available for clofibric acid and Dementia
| Article | Year |
|---|---|
APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.
Topics: Aged; Aged, 80 and over; Apolipoprotein E4; Apolipoproteins E; Causality; Cholesterol; Clofibric Aci | 2005 |